| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sana Biotechnology, Inc. | 10%+ Owner | Common Stock | 12,446,022 | $68,453,121 | $5.50 | 08 Feb 2024 | Indirect |
| 908 Devices Inc. | Director, 10%+ Owner | Common Stock | 5,725,045 | $26,621,459 | $4.65 | 11 Jun 2025 | Indirect |
| DA32 Life Science Tech Acquisition Corp. | Director, 10%+ Owner | Class A Common Stock | 650,000 | $6,500,000 | $10.00 | 28 Jul 2023 | Through DA32 Sponsor LLC |
| Twist Bioscience Corp | Director | Common Stock | 76,047 | $3,753,072 | $49.35 | 05 Feb 2025 | By Keith L. Crandell Trust |
| Quanterix Corp | Director | Common Stock | 131,236 | $3,531,561 | $26.91 | 03 Apr 2023 | Direct |
| Twist Bioscience Corp | Director | Common Stock | 22,476 | $1,109,236 | $49.35 | 05 Feb 2025 | Direct |
| 908 Devices Inc. | Director, 10%+ Owner | Common Stock | 25,291 | $117,603 | $4.65 | 11 Jun 2025 | Direct |
| 908 Devices Inc. | Director, 10%+ Owner | Stock Option (option to buy) | 6,516 | $27,993 | $1.75 | 12 Jun 2025 | Direct |
| Boundless Bio, Inc. | 10%+ Owner | Common Stock | 1,181,766 | 02 Apr 2024 | Indirect | ||
| 908 Devices Inc. | Director, 10%+ Owner | Restricted Stock Units | 14,083 | 12 Jun 2025 | Direct | ||
| Quanterix Corp | Director | Stock Option (Right to Buy) | 12,124 | 03 Jan 2023 | Direct | ||
| Boundless Bio, Inc. | 10%+ Owner | Series A Convertible Preferred Stock | 0 | 02 Apr 2024 | Indirect | ||
| Boundless Bio, Inc. | 10%+ Owner | Series B Convertible Preferred Stock | 0 | 02 Apr 2024 | Indirect | ||
| Boundless Bio, Inc. | 10%+ Owner | Series C Convertible Preferred Stock | 0 | 02 Apr 2024 | Indirect | ||
| DA32 Life Science Tech Acquisition Corp. | Director, 10%+ Owner | Class A Common Stock | 0 | $10.00 | 28 Jul 2023 | Through ARCH Venture Fund XI, L.P. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MASS | 908 Devices Inc. | 11 Jun 2025 | 4 | $0 | 4 | Director, 10%+ Owner | 13 Jun 2025, 16:18 |
| TWST | Twist Bioscience Corp | 05 Feb 2025 | 1 | $0 | 4 | Director | 07 Feb 2025, 17:16 |
| MASS | 908 Devices Inc. | 12 Jun 2024 | 4 | $0 | 4 | Director, 10%+ Owner | 14 Jun 2024, 16:21 |
| BOLD | Boundless Bio, Inc. | 02 Apr 2024 | 12 | +$3,200,000 | 4 | 10%+ Owner | 04 Apr 2024, 16:30 |
| BOLD | Boundless Bio, Inc. | 27 Mar 2024 | 0 | $0 | 3 | 10%+ Owner | 27 Mar 2024, 19:56 |
| SANA | Sana Biotechnology, Inc. | 08 Feb 2024 | 3 | +$9,999,996 | 4 | 10%+ Owner | 12 Feb 2024, 17:43 |
| TWST | Twist Bioscience Corp | 06 Feb 2024 | 1 | $0 | 4 | Director | 09 Feb 2024, 16:10 |
| /report/000106299323016234-crandell-keith-2023-07-28 | DA32 Life Science Tech Acquisition Corp. | 28 Jul 2023 | 1 | $0 | 4 | Director, 10%+ Owner | 10 Aug 2023, 20:28 |
| MASS | 908 Devices Inc. | 14 Jun 2023 | 4 | $0 | 4 | Director, 10%+ Owner | 16 Jun 2023, 17:52 |
| QTRX | Quanterix Corp | 03 Apr 2023 | 1 | +$13,057 | 4 | Director | 04 Apr 2023, 18:23 |
| TWST | Twist Bioscience Corp | 07 Feb 2023 | 1 | $0 | 4 | Director, 10%+ Owner | 09 Feb 2023, 17:08 |
| QTRX | Quanterix Corp | 03 Jan 2023 | 3 | +$13,053 | 4 | Director | 04 Jan 2023, 15:03 |
| QTRX | Quanterix Corp | 03 Oct 2022 | 1 | +$13,896 | 4 | Director | 05 Oct 2022, 16:04 |
| QTRX | Quanterix Corp | 01 Jul 2022 | 1 | +$14,993 | 4 | Director, 10%+ Owner | 06 Jul 2022, 16:07 |
| MASS | 908 Devices Inc. | 15 Jun 2022 | 4 | $0 | 4 | Director, 10%+ Owner | 17 Jun 2022, 16:15 |
| QTRX | Quanterix Corp | 01 Apr 2022 | 1 | +$14,991 | 4 | Director, 10%+ Owner | 05 Apr 2022, 16:42 |
| TWST | Twist Bioscience Corp | 08 Feb 2022 | 1 | $0 | 4 | Director | 10 Feb 2022, 18:32 |
| QTRX | Quanterix Corp | 03 Jan 2022 | 9 | +$13,020 | 4 | Director, 10%+ Owner | 05 Jan 2022, 15:06 |
| QTRX | Quanterix Corp | 01 Oct 2021 | 7 | +$13,000 | 4 | Director, 10%+ Owner | 05 Oct 2021, 16:02 |
| TWST | Twist Bioscience Corp | 12 Aug 2021 | 15 | -$4,815,377 | 4 | Director | 13 Aug 2021, 18:35 |
| /report/000089924321032269-crandell-keith-2021-08-05 | DA32 Life Science Tech Acquisition Corp. | 05 Aug 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 09 Aug 2021, 20:35 |
| /report/000089924321031427-crandell-keith-2021-07-30 | DA32 Life Science Tech Acquisition Corp. | 30 Jul 2021 | 2 | +$22,500,000 | 4 | Director, 10%+ Owner | 03 Aug 2021, 21:12 |
| /report/000089924321030231-crandell-keith-2021-07-27 | DA32 Life Science Tech Acquisition Corp. | 27 Jul 2021 | 0 | $0 | 3 | Director, 10%+ Owner | 27 Jul 2021, 21:51 |
| QTRX | Quanterix Corp | 01 Jul 2021 | 10 | +$12,967 | 4 | Director | 06 Jul 2021, 17:17 |
| MASS | 908 Devices Inc. | 17 Jun 2021 | 2 | $0 | 4 | Director, 10%+ Owner | 21 Jun 2021, 08:07 |
| QTRX | Quanterix Corp | 01 Apr 2021 | 7 | +$12,966 | 4/A | Director | 06 Jul 2021, 17:17 |